A new report from Vizient highlighted the 10 drug shortages placing the most pressure on U.S. hospitals, with the injectable lorazepam topping the list for both general and pediatric facilities.  The following are the top 10 high-impact drug shortages reported…

The FDA has approved Gilead Sciences’ lenacapavir, a twice-yearly injectable medication to prevent HIV, making it the first drug approved for adults and adolescents who are at risk.  The FDA’s approval is based on data from a Phase 3 trial…

Hospital labor costs related to drug shortage management have significantly increased, from $359 million in 2019 to $894 million in 2024 — a nearly 150% increase, according to a Vizient report published June 17.  Vizient surveyed 132 of its clients…

The FDA has delayed its decision to approve a new treatment for hereditary angioedema, citing a heavy workload and limited resources.  The drug, sebetralstat, developed by Kalvista Pharmaceuticals, was scheduled for a decision by June 17 under the Prescription Drug…

Mark Cuban’s Cost Plus Drug Co. and virtual care provider 9amHealth have partnered to offer obesity medications through a new program targeting self-insured employers.  Under the partnership, 9amHealth will use low-cost oral obesity medications sourced from Cost Plus Drugs alongside…

The FDA is launching a National Priority Voucher program to accelerate reviews of certain new drug applications. The agency will distribute a limited number of vouchers in the program’s first year to drugmakers “aligned with U.S. national priorities,” according to…

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles.  CMS gained the authority to negotiate list prices with drug manufacturers in 2022 with the Inflation Reduction Act. The law ended a 19-year…

New Orleans-based Ochsner Health has signed a new three-year agreement with Latent Health to expand the use of AI tools that streamline medication prior authorizations across its network.  The partnership builds on an initial collaboration launched in November 2023 to…

After nearly three decades at University of Toledo Medical Center, from inpatient pharmacist to hospital executive, Russell Smith, PharmD, is now applying his extensive clinical background to lead hospital operations as the new chief operating officer.  Question: You began your…

A study found that a once-daily pill called obicetrapib significantly lowered LDL cholesterol in patients at high risk for heart disease.  The clinical trial, published May 7 in The New England Journal of Medicine, enrolled 2,500 participants with either a…